miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway

Abstract

Background Gastric cancer (GC) is a deadly malignancy worldwide. In the past, it has been shown that cellular signaling pathway alterations play a crucial role in the development of GC. In particular, deregulation of the PI3K/AKT/mTOR pathway seems to affect multiple GC functions including growth, proliferation, metabolism, motility and angiogenesis. Targeting alterations in this pathway by microRNAs (miRNAs) represents a potential therapeutic strategy, especially in inhibitor-resistant tumors. The objective of this study was to evaluate the expression of 3 pre-selected miRNAs, miR-101-2, miR-125b-2 and miR-451a, in a series of primary GC tissues and matched non-GC tissues and in several GC-derived cell lines, and to subsequently evaluate the functional role of these miRNAs. Methods Twenty-five primary GC samples, 25 matched non-GC samples and 3 GC-derived cell lines, i.e., AGS, MKN28 and MKN45, were included in this study. miRNA and target gene expression levels were assessed by quantitative RT-PCR and western blotting, respectively. Subsequently, cell viability, clone formation, cell death, migration and invasion assays were performed on AGS cells. Results miR-101-2, miR-125b-2 and miR-451a were found to be down-regulated in the primary GC tissues and the GC-derived cell lines tested. MiRNA mimic transfections significantly reduced cell viability and colony formation, increased cell death and reduced cell migration and invasion in AGS cells. We also found that exogenous expression of miR-101-2, miR-125b-2 and miR-451a decreased the expression of their putative targets MTOR, PIK3CB and TSC1, respectively. Conclusions Our expression analyses and in vitro functional assays suggest that miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in primary GCs as well as in GC-derived AGS cells.

What people with Down Syndrome can teach us about cardiopulmonary disease

“…For example, high levels of the miRNA Let-7c induce cell cycle arrest by targeting CDC25a [99]. Similarly, the tumour suppressor activities of Hsa21-encoded miR-99a [100] and miR-125b-2 [101] could contribute to lung hypoplasia. The biology of the lung in Down syndrome can also be affected by overexpression of Hsa21 genes in nonresident cells.…”

miR-146a and miR-146b promote proliferation, migration and invasion of follicular thyroid carcinoma via inhibition of ST8SIA4

“…Moreover, miRNAs have been reported to stimulate the PI3K-AKT-mTOR pathway in various diseases [21–23]. Therefore, we sought to determine whether PI3K-AKT-mTOR signalling is regulated by the ST8SIA family and miRNAs in FTC.…”

MiR-17-5p regulates cell proliferation and migration by targeting transforming growth factor-β receptor 2 in gastric cancer

“…Oncogenic miRNAs block the function of certain mRNAs, of tumor suppressors whereas tumor suppressive miRNAs produce an anti-tumor effect [10, 11]. Several studies have reported that miRNAs can regulate several aspects of human gastric cancer pathogenesis, including metastasis, invasion, and self-renewal by targeting the EGR2 [12], MAPK [13] and PI3K/AKT signaling pathways [14]. Therefore, targeting specific miRNAs could be a possible alternative for the treatment of gastric cancer.…”